 |
|
PET/CT planning beneficial for head and neck cancer patients
March 05, 2008Combining imaging modalities provides excellent clinical outcomes
Using a combination of positron emission tomography (PET) and computed tomography for radiation therapy treatment planning in head and neck carcinoma patients provides for excellent, local and regional disease control when compared to CT alone, according to a study in the March 1 issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
CT has been the traditional choice for staging and radiation therapy treatment planning for head and neck squamous cell carcinomas, which account for approximately 5 percent of malignancies worldwide; but PET has been shown to have advantages over CT and other imaging modalities in detecting primary tumors, involved lymph nodes and distant metastatic disease not clearly otherwise identified. PET alone does have several disadvantages though, such as poor correlation to precise anatomic structures, but these negative impacts are significantly reduced when PET and CT are combined by fusing the separate scans taken on a hybrid scanner.
While it has been proven in several studies that PET/CT imaging is feasible for head and neck radiation therapy planning, very few studies have been done to determine the clinical outcomes. So, researchers in the departments of Radiation Oncology, Radiology, Neoplastic and Related Disorders, and Otolaryngology at the Medical College of Wisconsin in Milwaukee conducted this study to evaluate the clinical outcomes, including overall survival, disease-free survival and the incidence of recurrence of patients receiving PET/CT-guided radiation therapy and the correlation of the clinical outcomes to the maximum standard uptake value obtained on the PET scan.
Between December 2002 and August 2006, 42 patients with a median age of 55, who were diagnosed with head and neck squamous cell carcinoma, were given PET/CT imaging as part of their radiation therapy planning. All patients were observed for at least six months following their treatment, with a mean follow-up time of 32 months.
Overall survival of the 42 study patients was 82.8 percent at two years and 74.1 percent at three years, superior to the survival rate that was found in a Radiation Therapy Oncology Group study in which patients received standard fractionation or accelerated fractionation with concomitant boost. That study was the largest randomized trial of radiation therapy in locally advanced head and neck cancer.
Disease free survival for the 42 study patients was 71 percent and 66.9 percent at two and three years respectively. The cumulative incidence of recurrence was 18.7 percent. The study also found that standard uptake value is not a good predictor of local recurrence and that dose escalation based on standard uptake value is unlikely to be a fruitful treatment strategy.
"PET/CT provides a higher level of confidence that we are not missing tumors as we attempt to lessen treatment side effects by delivering radiation therapy that tightly conforms in three dimensions to a given tumor volume," said Christopher Schultz, M.D., professor of radiation oncology at the Medical College of Wisconsin. "Most importantly the PET/CT guided conformal radiotherapy was clearly no worse, and based on our early results may in fact lead to superior clinical outcomes as compared to CT only planned radiotherapy."
American Society for Therapeutic Radiology and Oncology
While it has been proven in several studies that PET/CT imaging is feasible for head and neck radiation therapy planning, very few studies have been done to determine the clinical outcomes. So, researchers in the departments of Radiation Oncology, Radiology, Neoplastic and Related Disorders, and Otolaryngology at the Medical College of Wisconsin in Milwaukee conducted this study to evaluate the clinical outcomes, including overall survival, disease-free survival and the incidence of recurrence of patients receiving PET/CT-guided radiation therapy and the correlation of the clinical outcomes to the maximum standard uptake value obtained on the PET scan.
Between December 2002 and August 2006, 42 patients with a median age of 55, who were diagnosed with head and neck squamous cell carcinoma, were given PET/CT imaging as part of their radiation therapy planning. All patients were observed for at least six months following their treatment, with a mean follow-up time of 32 months.
Overall survival of the 42 study patients was 82.8 percent at two years and 74.1 percent at three years, superior to the survival rate that was found in a Radiation Therapy Oncology Group study in which patients received standard fractionation or accelerated fractionation with concomitant boost. That study was the largest randomized trial of radiation therapy in locally advanced head and neck cancer.
Disease free survival for the 42 study patients was 71 percent and 66.9 percent at two and three years respectively. The cumulative incidence of recurrence was 18.7 percent. The study also found that standard uptake value is not a good predictor of local recurrence and that dose escalation based on standard uptake value is unlikely to be a fruitful treatment strategy.
"PET/CT provides a higher level of confidence that we are not missing tumors as we attempt to lessen treatment side effects by delivering radiation therapy that tightly conforms in three dimensions to a given tumor volume," said Christopher Schultz, M.D., professor of radiation oncology at the Medical College of Wisconsin. "Most importantly the PET/CT guided conformal radiotherapy was clearly no worse, and based on our early results may in fact lead to superior clinical outcomes as compared to CT only planned radiotherapy."
American Society for Therapeutic Radiology and Oncology
Radiation Therapy Current Events and Radiation Therapy News RSSPET imaging response a prognostic factor after thoracic radiation therapy for lung cancer
A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting.
Chemo-radiation before prostate removal may prevent cancer recurrence
Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival.
Radiation therapy technique successfully treats pain in patients with advanced cancer
Stereotactic radiosurgery (SRS), a radiation therapy procedure pioneered at the University of Pittsburgh Cancer Institute (UPCI) that precisely delivers a large dose of radiation to tumors, effectively controls pain in patients with cancer that has spread to the spine.
Aiming to avoid damage to neurocognitive areas of the brain during cranial radiation
Radiation oncologists at Rush University Medical Center are intent on finding ways to avoid damage to the critically important hippocampus and limbic circuit of the brain when cranial radiation is required to treat existing or potential metastatic cancers.
Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer
Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results.
Stereotactic radiotherapy offers noninvasive, effective treatment for frail patients with early-stage lung cancer
Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians.
Preventative brain radiation for lung cancer patients: Benefits and risks
A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain.
Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancer
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone.
Adapting Space-Industry Technology to Treat Breast Cancer
Researchers at Rush University Medical Center and Argonne National Laboratory are collaborating on a study to determine if an imaging technique used by NASA to inspect the space shuttle can be used to predict tissue damage often experienced by breast cancer patients undergoing radiation therapy.
URI research couple's method targets cancerous tumors
Two University of Rhode Island associate professors, biophysicists Yana Reshetnyak and Oleg Andreev, have discovered a technology that can detect cancerous tumors and deliver treatment to them without the harming the healthy cells surrounding them, thereby significantly reducing side effects.
More Radiation Therapy Current Events and Radiation Therapy News Articles
 |
Principles and Practice of Radiation Therapy by Charles M. Washington MBA RT(T) FASRT (Author), Dennis T. Leaver MS RT(R)(T) FASRT (Author) Learn everything you need to know about radiation therapy with the only comprehensive text written for radiation therapy students by radiation therapists. Principles and Practice of Radiation Therapy is designed to help you understand cancer management, improve clinical techniques for delivering doses of radiation, and apply complex concepts to treatment planning and delivery. This edition features enhanced learning tools and thoroughly updated content, including three new chapters to inform you of increasingly important technologies and practices. The up-to-date and authoritative coverage of this text make it a resource you'll want to consult throughout your radiation therapy courses and beyond. Complete coverage of radiation therapy provides all introductory content plus the full... |
 |
The Physics of Radiation Therapy by Faiz M Khan (Author) Dr. Khan's classic textbook on radiation oncology physics is now in its thoroughly revised and updated Fourth Edition. It provides the entire radiation therapy team--radiation oncologists, medical physicists, dosimetrists, and radiation therapists--with a thorough understanding of the physics and practical clinical applications of advanced radiation therapy technologies, including 3D-CRT, stereotactic radiotherapy, HDR, IMRT, IGRT, and proton beam therapy. These technologies are discussed along with the physical concepts underlying treatment planning, treatment delivery, and dosimetry. This Fourth Edition includes brand-new chapters on image-guided radiation therapy (IGRT) and proton beam therapy. Other chapters have been revised to incorporate the most recent developments in the field.... |
 |
Radiation Therapy Planning by Gunilla Bentel (Author) All new expanded edition provides step-by-step guidelines on performing the technical aspects of radiation therapy. Important new coverage includes treatment preparation, 3-D treatment planning, dosimetry, new technologies, documentation, and quality assurance. In addition, you'll find added treatment planning guidelines by body region, and an expanded art program including many new 4-color illustrations. |
 |
The Best News About Radiation Therapy: Everything You Need to Know About Your Treatment by Carol Kornmehl (Author) Dr. Carol Kornmehl guides patients through this intimidating process, explaining each step of the therapy and the results they can expect from there treatment. |
|
Radiation Therapy Planning: Including Problems And Solutions by Gunilla C. Bentel (Author) | |
 |
SolRX Radx Radiation Therapy Cream by SOLRX Radiation therapy was developed with 2% lidocaine to prevent radiation dermitis and to relieve many and in some cases all of the skin related side effects of radiation therapy. |
 |
A Guide for Delineation of Lymph Nodal Clinical Target Volume in Radiation Therapy by Giampiero Ausili Cefaro (Editor), Carlos A. Perez (Editor), Domenico Genovesi (Editor), Annamaria Vinciguerra (Editor) Conformal radiotherapy offers the opportunity to enhance precise delivery of high dose radiation to the target volume while maintaining normal tissues doses at acceptable tolerance levels. This technique requires an exact definition of the treatment volumes: gross tumour volume (GTV), clinical target volume (CTV) and planning target volume (PTV). For this reason, it is important to have a very good knowledge of radiological anatomy and natural history of the disease. In particular, CTV is a tissue volume that contains the macroscopic disease with the surrounding areas suspected of subclinical involvement (CTV) and regional lymph nodes (CTV2). Delivery of adequate doses of irradiation to lymph nodes at risk, enhances treatment outcome and selective irradiation of them decreases... |
 |
Essential Oil - Radiation Therapy Wellness Oil - 2 Ounces - Certified Organic - Made in USA by NI There's nothing fun about going through radiation. We've created this formula with your physical and mental wellbeing in mind. Physically, lavender has powerful healing properties for burn victims. In fact, aromatherapy was founded on this very concept! Mentally, lavender essential oil can be calming and uplifting at the same time. It is our hope that you find some calm as you heal physically while using this oil. While generally regarded as safe during pregnancy, it's is always a good idea to check with your doctor before using any product. Safe to use on children over the age of two years . |
 |
Radiation Therapy: A Guide to Patient Care by Marilyn Haas PhD RN CNS ANP-C (Author), William Hogle RN MSN OCN (Author), Giselle Moore-Higgs ARNP PhD(c) AOCN (Author), Tracy Gosselin Acomb RN MSN AOCN (Author) Focusing on radiation oncology, this resource also provides information on combined modality (chemotherapy/radiation), newer technology, evidence-based guidelines, special patient populations, and in-depth management interventions and patient teaching. In addition to the comprehensive presentations of cancer sites and radiobiology, Radiation Therapy has new special topics on supportive nursing care and clinical practice, addressing the needs of personnel caring for radiation therapy patients in various situations. UNIQUE! Covers care of patients receiving radiation or combined therapies (chemo/radiation).Integrative Systems and Cancer Sites detailed in 13 core chapters.An entire section on adjuvant therapies.Includes several chapters devoted to special treatment modalities.A... |
 |
Halloween radiation therapy (Primary Contributor) |
| © 2009 BrightSurf.com |